Search Results 151-160 of 17810 for Crohns disease

1. A Study to Evaluate Posaconazole to Treat Genetically-defined Patients with Active Crohn's Disease - Mayo Clinic

   A Study to Evaluate Posaconazole to Treat Genetically-defined Patients with Active Crohn's Disease · Share · Facebook · Twitter.

2. A Study to Evaluate Impact of COVID-19 on Inflammatory Bowel Disease - Mayo Clinic

   ... IBD patients, including infection rates and complications from SARS-COV2, IBD ... Participant eligibility includes age, gender, type and stage of disease, and ...

3. A Study to Evaluate Darvadstrocel in the Treatment of Complex Perianal Fistula in Crohn's Disease Patients - Mayo Clinic

   The purpose of this study is to evaluate the long-term safety of a single dose of darvadstrocel in participants with Crohn's disease (CD) and complex perianal ...

4. Crohn's disease - Doctors and departments - Mayo Clinic

   Learn about symptoms and treatment for this debilitating, but treatable, digestive condition.

5. Anal Fistula Clinical Trials

   The purpose of this study is to evaluate the long-term safety of a single dose of darvadstrocel in participants with Crohn's disease (CD) and complex perianal ...

6. A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI) - Mayo Clinic

   A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI) · Share ...

7. A Study to Test the Safety and Effectiveness of PF-00547659 for Patients who have Crohn's Disease - Mayo Clinic

   The purpose of this study is to assess the safety and effectiveness of PF-00547659 (experimental drug) for patients who have Crohn's disease that is clinically ...

8. A Study to Evaluate Remicade (Infliximab) for the Prevention of Recurrence in Crohn's Disease Patients Undergoing Surgical Resection and are at an Increased Risk of Recurrence - Mayo Clinic

   ... Crohn's disease and may be useful in preventing a relapse of Crohn's disease after surgical resection. Participation eligibility. Participant eligibility ...

9. Francis A. Farraye, M.D., M.S. - Doctors and Medical Staff - Mayo Clinic

   ... Crohn's Disease. His newest book, published in 2022 is Mayo Clinic on Crohn's Disease and Ulcerative Colitis. Dr. Farraye is a Fellow of the American ...

10. Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease - Mayo Clinic

    Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease · Overview · Participation eligibility · Participating Mayo Clinic ...